Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2013

01-08-2013 | Case Report

Anorectal fistula is an early manifestation of Crohn’s disease that occurs before bowel lesions advance: a study of 11 cases

Authors: Naoto Saigusa, Tadashi Yokoyama, Masaru Shinozaki, Ryoji Miyahara, Tsuyoshi Konishi, Toshio Nakamura, Yasuhisa Yokoyama

Published in: Clinical Journal of Gastroenterology | Issue 4/2013

Login to get access

Abstract

The diagnostic significance of single-balloon enteroscopy (SBE) in patients presenting with Crohn’s disease (CD)-like anorectal fistula is unknown. We experienced 11 cases undergoing SBE due to CD-like fistulas between December 2007 and April 2013. The mean interval from fistula onset to SBE was 19.2 months with a range of 1.3−44.7. Prior to SBE, all patients underwent anorectal examination under anesthesia (EUA), and 9 patients underwent total colonoscopy with terminal ileal cannulation (TCS-I). One of 7 patients undergoing upper gastrointestinal endoscopy had CD-like gastritis. EUA revealed CD fissures in 7 patients, 1 of whom had no intestinal lesion. Primary TCS-I identified early lesions, such as aphthes and small ulcers, in 4 patients. Among the other 5 patients without any intestinal lesions with TCS-I, SBE indicated early lesions in 3 patients. One of 2 patients who initially underwent SBE without TCS-I showed multiple aphthes. Of the 11 patients, only 4 patients fulfilled the definitive Japanese diagnostic criteria for CD and 7 remained ‘suspected CD’ cases. Intrinsic anorectal fistulas as a presenting symptom of CD may be an early predictor of bowel lesions. SBE has the potential to reveal incipient disease because an early ileal lesion is not rare for patients with anorectal fistulas.
Literature
1.
go back to reference Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–55.PubMedCrossRef Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–55.PubMedCrossRef
2.
go back to reference D’Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet. 2008;371:660–7.PubMedCrossRef D’Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet. 2008;371:660–7.PubMedCrossRef
3.
go back to reference Ordás I, Feagan BG, Sandborn WJ. Early use of immunosuppressives or TNF antagonists for the treatment of Crohn’s disease: time for a change. Gut. 2011;60:1754–63.PubMedCrossRef Ordás I, Feagan BG, Sandborn WJ. Early use of immunosuppressives or TNF antagonists for the treatment of Crohn’s disease: time for a change. Gut. 2011;60:1754–63.PubMedCrossRef
4.
go back to reference Parashette KR, Makam RC, Cuffari C. Infliximab therapy in pediatric Crohn’s disease. Clin Exp Gastroenterol. 2010;3:57–63.PubMedCrossRef Parashette KR, Makam RC, Cuffari C. Infliximab therapy in pediatric Crohn’s disease. Clin Exp Gastroenterol. 2010;3:57–63.PubMedCrossRef
5.
go back to reference Bernstein CN, Loftus EV Jr, Ng SC, Lakatos PL, Moum B. Hospitalisations and surgery in Crohn’s disease. Gut. 2012;61:622–9.PubMedCrossRef Bernstein CN, Loftus EV Jr, Ng SC, Lakatos PL, Moum B. Hospitalisations and surgery in Crohn’s disease. Gut. 2012;61:622–9.PubMedCrossRef
6.
go back to reference Schreiber S, Colombel J, Panes J, Scholmerich J, McColm J, Sandborn W. Recent onset Crohn’s disease shows higher remission rates and durability of response to treatment with subcutaneous monthly certolizumab pegol: results from the analysis of the PRECISE 2 phase III study. Gut. 2006;55:A108.CrossRef Schreiber S, Colombel J, Panes J, Scholmerich J, McColm J, Sandborn W. Recent onset Crohn’s disease shows higher remission rates and durability of response to treatment with subcutaneous monthly certolizumab pegol: results from the analysis of the PRECISE 2 phase III study. Gut. 2006;55:A108.CrossRef
7.
go back to reference Ricart E, García-Bosch O, Ordás I, Panés J. Are we giving biologics too late? The case for early versus late use. World J Gastroenterol. 2008;36:5523–7.CrossRef Ricart E, García-Bosch O, Ordás I, Panés J. Are we giving biologics too late? The case for early versus late use. World J Gastroenterol. 2008;36:5523–7.CrossRef
8.
go back to reference Adler SN, Yoav M, Eitan S, Yehuda C, Eliakim R. Does capsule endoscopy have an added value in patients with perianal disease and a negative work up for Crohn’s disease? World J Gastrointest Endosc. 2012;4:185–8.PubMedCrossRef Adler SN, Yoav M, Eitan S, Yehuda C, Eliakim R. Does capsule endoscopy have an added value in patients with perianal disease and a negative work up for Crohn’s disease? World J Gastrointest Endosc. 2012;4:185–8.PubMedCrossRef
9.
go back to reference Mensink PB, Groenen MJ, van Buuren HR, Kuipers EJ, van der Woude CJ. Double-balloon enteroscopy in Crohn’s disease patients suspected of small bowel activity: findings and clinical impact. J Gastroenterol. 2009;44:271–6.PubMedCrossRef Mensink PB, Groenen MJ, van Buuren HR, Kuipers EJ, van der Woude CJ. Double-balloon enteroscopy in Crohn’s disease patients suspected of small bowel activity: findings and clinical impact. J Gastroenterol. 2009;44:271–6.PubMedCrossRef
10.
go back to reference Naganuma M, Watanabe M, Hibi T. Safety and usefulness of balloon endoscopy in Crohn’s disease patients with postoperative ileal lesions. J Crohns Colitis. 2011;5:73–4.PubMedCrossRef Naganuma M, Watanabe M, Hibi T. Safety and usefulness of balloon endoscopy in Crohn’s disease patients with postoperative ileal lesions. J Crohns Colitis. 2011;5:73–4.PubMedCrossRef
11.
go back to reference Mensink PB, Aktas H, Zelinkova Z, West RL, Kuipers EJ, van der Woude CJ. Impact of double-balloon enteroscopy findings on the management of Crohn’s disease. Scand J Gastroenterol. 2010;45:483–9.PubMedCrossRef Mensink PB, Aktas H, Zelinkova Z, West RL, Kuipers EJ, van der Woude CJ. Impact of double-balloon enteroscopy findings on the management of Crohn’s disease. Scand J Gastroenterol. 2010;45:483–9.PubMedCrossRef
12.
go back to reference Ueno F, Matsui T, Matsumoto T, Matsuoka K, Watanabe M, Hibi T, On Behalf of the Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology. Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013;48:31–72.PubMedCrossRef Ueno F, Matsui T, Matsumoto T, Matsuoka K, Watanabe M, Hibi T, On Behalf of the Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology. Evidence-based clinical practice guidelines for Crohn’s disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013;48:31–72.PubMedCrossRef
13.
go back to reference Matsui T, Hirai F, Hisabe T. Proposed diagnostic criteria for Crohn’s disease. Annual reports of the research group of intractable inflammatory bowel disease subsidized by the Ministry of Health, Labour, and Welfare of Japan, Tokyo, Japan; 2011. p. 52–4 (in Japanese). Matsui T, Hirai F, Hisabe T. Proposed diagnostic criteria for Crohn’s disease. Annual reports of the research group of intractable inflammatory bowel disease subsidized by the Ministry of Health, Labour, and Welfare of Japan, Tokyo, Japan; 2011. p. 52–4 (in Japanese).
14.
go back to reference Tsujikawa T, Saitoh Y, Andoh A, Imaeda H, Hata K, Minematsu H, et al. Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy. 2008;40:11–5.PubMedCrossRef Tsujikawa T, Saitoh Y, Andoh A, Imaeda H, Hata K, Minematsu H, et al. Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy. 2008;40:11–5.PubMedCrossRef
15.
go back to reference Gray BK, Lockhartmummery HE, Morson BC. Crohn’s disease of the anal region. Gut. 1965;6:515–24.PubMedCrossRef Gray BK, Lockhartmummery HE, Morson BC. Crohn’s disease of the anal region. Gut. 1965;6:515–24.PubMedCrossRef
16.
go back to reference Nordgren S, Fasth S, Hultén L. Anal fistulas in Crohn’s disease: incidence and outcome of surgical treatment. Int J Colorectal Dis. 1992;7:214–8.PubMedCrossRef Nordgren S, Fasth S, Hultén L. Anal fistulas in Crohn’s disease: incidence and outcome of surgical treatment. Int J Colorectal Dis. 1992;7:214–8.PubMedCrossRef
17.
go back to reference Ruffolo C, Citton M, Scarpa M, Angriman I, Massani M, Caratozzolo E, et al. Perianal Crohn’s disease: is there something new? World J Gastroenterol. 2011;17:1939–46.PubMedCrossRef Ruffolo C, Citton M, Scarpa M, Angriman I, Massani M, Caratozzolo E, et al. Perianal Crohn’s disease: is there something new? World J Gastroenterol. 2011;17:1939–46.PubMedCrossRef
19.
go back to reference Coremans G, Dockx S, Wyndaele J, Hendrickx A. Do anal fistulas in Crohn’s disease behave differently and defy Goodsall’s rule more frequently than fistulas that are cryptoglandular in origin? Am J Gastroenterol. 2003;98:2732–5.PubMedCrossRef Coremans G, Dockx S, Wyndaele J, Hendrickx A. Do anal fistulas in Crohn’s disease behave differently and defy Goodsall’s rule more frequently than fistulas that are cryptoglandular in origin? Am J Gastroenterol. 2003;98:2732–5.PubMedCrossRef
20.
go back to reference Hughes LE. Surgical pathology and management of anorectal Crohn’s disease. J R Soc Med. 1978;71:644–51.PubMed Hughes LE. Surgical pathology and management of anorectal Crohn’s disease. J R Soc Med. 1978;71:644–51.PubMed
21.
go back to reference Beaugerie L, Sokol H. Clinical, serological and genetic predictors of inflammatory bowel disease course. World J Gastroenterol. 2012;18:3806–13.PubMedCrossRef Beaugerie L, Sokol H. Clinical, serological and genetic predictors of inflammatory bowel disease course. World J Gastroenterol. 2012;18:3806–13.PubMedCrossRef
22.
go back to reference Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, et al. Early mucosal changes in Crohn’s disease. Gut. 1993;34:375–81.PubMedCrossRef Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, et al. Early mucosal changes in Crohn’s disease. Gut. 1993;34:375–81.PubMedCrossRef
23.
24.
go back to reference Oshitani N, Yukawa T, Yamagami H, Inagawa M, Kamata N, Watanabe K, et al. Evaluation of deep small bowel involvement by double-balloon enteroscopy in Crohn’s disease. Am J Gastroenterol. 2006;101:1484–9.PubMedCrossRef Oshitani N, Yukawa T, Yamagami H, Inagawa M, Kamata N, Watanabe K, et al. Evaluation of deep small bowel involvement by double-balloon enteroscopy in Crohn’s disease. Am J Gastroenterol. 2006;101:1484–9.PubMedCrossRef
25.
go back to reference Zisman TL, Rubin DT. Novel diagnostic and prognostic modalities in inflammatory bowel disease. Gastroenterol Clin North Am. 2009;38:729–52.PubMedCrossRef Zisman TL, Rubin DT. Novel diagnostic and prognostic modalities in inflammatory bowel disease. Gastroenterol Clin North Am. 2009;38:729–52.PubMedCrossRef
26.
go back to reference Munkholm P, Binder V. Clinical features and natural history of Crohn’s disease. In: Sartor RB, Sandborn WJ, editors. Kirsner’s inflammatory bowel diseases. Edinburgh: Saunders; 2004. p. 289–300. Munkholm P, Binder V. Clinical features and natural history of Crohn’s disease. In: Sartor RB, Sandborn WJ, editors. Kirsner’s inflammatory bowel diseases. Edinburgh: Saunders; 2004. p. 289–300.
27.
go back to reference Present DH. Crohn’s fistula: current concepts in management. Gastroenterology. 2003;124:1629–35.PubMedCrossRef Present DH. Crohn’s fistula: current concepts in management. Gastroenterology. 2003;124:1629–35.PubMedCrossRef
28.
go back to reference Chang DK, Kim JJ, Choi H, Eun CS, Han DS, Beyon JS, et al. Double balloon endoscopy in small intestinal Crohn’s disease and other inflammatory diseases such as cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). Gastrointest Endosc. 2007;66:S96–8.PubMedCrossRef Chang DK, Kim JJ, Choi H, Eun CS, Han DS, Beyon JS, et al. Double balloon endoscopy in small intestinal Crohn’s disease and other inflammatory diseases such as cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). Gastrointest Endosc. 2007;66:S96–8.PubMedCrossRef
29.
go back to reference Heine GD, Hadithi M, Groenen MJ, Kuipers EJ, Jacobs MA, Mulder CJ. Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy. 2006;38:42–8.PubMedCrossRef Heine GD, Hadithi M, Groenen MJ, Kuipers EJ, Jacobs MA, Mulder CJ. Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy. 2006;38:42–8.PubMedCrossRef
30.
go back to reference Solem CA, Loftus EV Jr, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, et al. Small-bowel imaging in Crohn’s disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc. 2008;68:255–66.PubMedCrossRef Solem CA, Loftus EV Jr, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, et al. Small-bowel imaging in Crohn’s disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc. 2008;68:255–66.PubMedCrossRef
31.
go back to reference Watanabe K, Hosomi S, Hirata N, et al. Efficacy and limitations of capsule endoscopy and double balloon endoscopy for small bowel pathologies of inflammatory bowel disease, especially Crohn’s Disease. Nihon Daicho Komonbyo Gakkai Zasshi. 2007;60:958–63.CrossRef Watanabe K, Hosomi S, Hirata N, et al. Efficacy and limitations of capsule endoscopy and double balloon endoscopy for small bowel pathologies of inflammatory bowel disease, especially Crohn’s Disease. Nihon Daicho Komonbyo Gakkai Zasshi. 2007;60:958–63.CrossRef
32.
go back to reference Eglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn’s disease in a population-based cohort. Dis Colon Rectum. 2012;55:773–7.PubMedCrossRef Eglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn’s disease in a population-based cohort. Dis Colon Rectum. 2012;55:773–7.PubMedCrossRef
33.
go back to reference Armuzzi A, Ahmad T, Ling KL, de Silva A, Cullen S, van Heel D, et al. Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31. Gut. 2003;52:1133–9.PubMedCrossRef Armuzzi A, Ahmad T, Ling KL, de Silva A, Cullen S, van Heel D, et al. Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31. Gut. 2003;52:1133–9.PubMedCrossRef
34.
go back to reference Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9:98–103.PubMedCrossRef Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9:98–103.PubMedCrossRef
Metadata
Title
Anorectal fistula is an early manifestation of Crohn’s disease that occurs before bowel lesions advance: a study of 11 cases
Authors
Naoto Saigusa
Tadashi Yokoyama
Masaru Shinozaki
Ryoji Miyahara
Tsuyoshi Konishi
Toshio Nakamura
Yasuhisa Yokoyama
Publication date
01-08-2013
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2013
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-013-0404-z

Other articles of this Issue 4/2013

Clinical Journal of Gastroenterology 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine